Dallas Innovates: Fort Worth Biotech Eyevensys Completes $30M Series B Funding Round

Dallas Innovates: Fort Worth Biotech Eyevensys Completes $30M Series B Funding Round

Dallas Innovates: Fort Worth Biotech Eyevensys Completes $30M Series B Funding Round 150 150 Eyevensys

Patricia Zilliox, CEO of Eyevensys gives insight on how Eyevensys plans to use the $30M funding raised from its Series B round.

Read More

Eyevensys Closes $30M Series B Financing
Dallas News: Paris and Fort Worth-based biotech company Eyevensys raises $30 million to develop treatments for eye diseases
Start Typing